drugset / Trial / NCT00641914

Inhaled Steroid Treatment as Regular Therapy in Early Asthma

NCT00641914

Phase 4 Completed 6800 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma. Patients will receive either Pulmicort or a non-active treatment for three years. Neither patients or investigators will be aware of the treatment received. After three years of treatment all patients will receive Pulmicort for 2 further years.

Timeline

Start
1996-10
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled

Indications